ArticleJournal of the American Heart Association2025
Risk of Poststroke Dementia in Patients With and Without Atrial Fibrillation: A Nationwide Cohort Study.
Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- NovelBiomedicines · 2026Article
- Rare TruncatingGenes · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtrial fibrillation (AF) is associated with an increased risk of dementia in nonstroke populations. We aimed to study whether AF was also associated with an increased risk of poststroke dementia (PSD).
methodsThis nationwide register-based cohort study included all patients with incident acute ischemic stroke (AIS) in Denmark from 2008 to 2017. Patients with AF were compared with patients without AF using propensity-score weighting. The primary outcome was PSD, determined as a diagnosis of dementia or use of dementia medication within 5 years from AIS. PSD hazard rates were compared between patients with and without AF using Cox proportional hazards regression. Dementia-free mortality risk was evaluated as a secondary outcome.
resultsWe included 61 058 patients with incident AIS, 12 248 with AF, and 48 810 without AF. Mean±SD age was 70.5±11.6, and 56.1% were men. A total of 3190 patients were diagnosed with dementia within a median of 2.1 (interquartile range, 0.82-4.2) years after AIS. In the unadjusted analysis, patients with AF had a higher PSD rate than patients without AF (19.0/1000 person-years versus 11.5/1000 person-years; hazard ratio [HR], 1.63 [95% CI, 1.51-1.77]). After adjustment for confounding factors, PSD risk was comparable between patients with and without AF (HR, 1.07 [95% CI, 0.97-1.17]). Dementia-free mortality risk was higher for patients with AF than patients without in both unadjusted (HR, 2.14 [95% CI, 2.07-2.21]) and adjusted analyses (HR, 1.31 [95% CI, 1.26-1.37]).
conclusionsAmong patients with AIS, AF was not associated with an increased risk of PSD, likely due to an increased mortality risk. Patients with AF may not be a particular PSD high-risk group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.